During the past decade, Aurora Research Institute conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora Research Institute" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "SI-BONE, Inc." with 2 trials sponsored and "Capricor Inc." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Research Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Arrowhead Regional Medical Center" with 1 trials as a collaborator, "Aurora Health Care" with 1 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator and "Bayview Medical Center" with 1 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Aurora Research Institute" are "Acne Vulgaris" (1 trials), "Acute Myocardial Infarction" (1 trials), "Adult Solid Tumor" (1 trials), "Advanced Solid Tumor" (1 trials) and "Aneurysm" (1 trials). Many other conditions were trialed in "Aurora Research Institute" in a lesser frequency.

Most popular intervention types in "Aurora Research Institute" are "Drug" (13 trials), "Device" (6 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "5-fluorouracil" (1 trials), "ACURATE Prime™ Transfemoral TAVR System XL" (1 trials), "ACURATE neo2™ Transfemoral TAVR System" (1 trials) and "Anti-hypertensive therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aurora Research Institute" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aurora Research Institute". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Aurora Research Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora Research Institute, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".